Patents by Inventor Peter Jürgen Cnota

Peter Jürgen Cnota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating underlying inflammation from COPD or asthma
    Patent number: 10537550
    Abstract: The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the NOVOLIZER®.
    Type: Grant
    Filed: August 11, 2008
    Date of Patent: January 21, 2020
    Assignee: MEDA PHARMA GMBH & CO. KG
    Inventors: Joachim Goede, Joachim Maus, Peter Jürgen Cnota, Istvan Szelenyi
  • Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
    Publication number: 20120076739
    Abstract: The invention relates to novel combinations based on anticholinergics, ?2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 29, 2012
    Applicant: Meda Pharma GmbH & Co., KG
    Inventors: Joachim MAUS, Horst KASTRUP, Istvan SZELENYI, Peter Jürgen CNOTA, Artur BAUHOFER
  • Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease
    Patent number: 8097605
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: January 17, 2012
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Joachim Maus, Peter Juergen Cnota, Istvan Szelenyi, Beatrix Fyrnys
  • Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
    Patent number: 8048910
    Abstract: Novel combinations based on anticholinergics, ?2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases. A particular combination comprises R,R-glycopyrrolate, rolipram, and budesonide, or physiologically acceptable salts thereof, wherein dosage amounts are such that a synergistic therapeutic effect is achieved.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 1, 2011
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Joachim Maus, Horst Kastrup, Istvan Szelenyi, Peter Jürgen Cnota, Artur Bauhofer
  • Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease
    Publication number: 20090136429
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R, R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Application
    Filed: February 3, 2009
    Publication date: May 28, 2009
    Inventors: Joachim Maus, Peter Juergen Cnota, Istvan Szelenyi, Beatrix Fyrnys